MARK LIEBREICH: Open Payments
NPI 1669418745 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 30 payments from 13 companies in 2025. Trend: 2023 $679 · 2024 $705 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $133 |
| PFIZER INC. | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $59 |
| Amgen Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: AIRSUPRA, PAXLOVID, Wegovy, REPATHA, SHINGRIX, SPRAVATO, Auvelity, UBRELVY.
Industry payments across PA — which companies pay providers there.
